Solaris Endovascular, Inc. announced that the DEScover clinical trial has completed enrollment. According to the comp ...
Enrollment milestone achieved ahead of schedule as Solaris DE drug-eluting continues to gather additional clinical ...
Investor's Business Daily on MSN
Data center power provider bolts higher, nearing a buy point
This data center power provider is climbing in a consolidation pattern and nearing a prior high. Analysts see 135% profit ...
The share price of Solaris Energy Infrastructure, Inc. (NYSE:SEI) surged by 14.64% between December 30, 2025, and January 6, ...
View source version on businesswire.com: https://www.businesswire.com/news/home/20251103631789/en/ The articles, information, and content displayed on this webpage ...
Revenue of $167 million increased 12% sequentially from second quarter 2025 due to activity growth within the Solaris Power Solutions segment. Net income of $25 million and $0.31 per diluted Class A ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback